Research Paper Volume 14, Issue 2 pp 845—868
Tumor microenvironment-related multigene prognostic prediction model for breast cancer
Figure 12. Durg-response analysis of (A) Paclitaxel. (B) Camptothecin. (C) Cytarabine. (D) Lapatinib. (E) Erlotinib. (F) Gefitinib.